Lindbrook Capital LLC decreased its stake in The Clorox Company (NYSE:CLX – Get Rating) by 23.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 799 shares of the company’s stock after selling 246 shares during the quarter. Lindbrook Capital LLC’s holdings in Clorox were worth $112,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Intelligent Financial Strategies bought a new position in shares of Clorox during the 4th quarter valued at about $36,000. Koshinski Asset Management Inc. increased its position in shares of Clorox by 23.7% during the fourth quarter. Koshinski Asset Management Inc. now owns 2,710 shares of the company’s stock worth $380,000 after acquiring an additional 520 shares in the last quarter. Empirical Finance LLC raised its holdings in shares of Clorox by 8.1% during the fourth quarter. Empirical Finance LLC now owns 3,269 shares of the company’s stock worth $459,000 after acquiring an additional 246 shares during the period. Louisiana State Employees Retirement System lifted its position in Clorox by 1.3% in the 4th quarter. Louisiana State Employees Retirement System now owns 8,000 shares of the company’s stock valued at $1,123,000 after acquiring an additional 100 shares in the last quarter. Finally, Park Avenue Securities LLC boosted its stake in Clorox by 6.0% in the 4th quarter. Park Avenue Securities LLC now owns 3,141 shares of the company’s stock worth $441,000 after purchasing an additional 179 shares during the period. Institutional investors own 79.12% of the company’s stock.
Analyst Upgrades and Downgrades
CLX has been the subject of a number of research reports. UBS Group increased their price objective on Clorox from $129.00 to $140.00 in a report on Friday, February 3rd. StockNews.com initiated coverage on shares of Clorox in a report on Thursday, March 16th. They set a “hold” rating for the company. Citigroup started coverage on Clorox in a report on Thursday, February 16th. They issued a “neutral” rating and a $155.00 price objective for the company. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $152.00 to $147.00 in a research report on Monday, March 20th. Finally, Barclays lowered their price target on Clorox from $110.00 to $108.00 and set an “underweight” rating on the stock in a research report on Monday, February 6th. Seven research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Clorox presently has an average rating of “Hold” and an average price target of $142.27.
Clorox Price Performance
Clorox (NYSE:CLX – Get Rating) last issued its quarterly earnings data on Thursday, February 2nd. The company reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.32. The company had revenue of $1.72 billion during the quarter, compared to analysts’ expectations of $1.66 billion. Clorox had a return on equity of 89.97% and a net margin of 6.16%. The business’s revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.66 earnings per share. Equities analysts forecast that The Clorox Company will post 4.23 EPS for the current year.
Clorox Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be given a dividend of $1.18 per share. This represents a $4.72 annualized dividend and a yield of 2.99%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox’s payout ratio is 134.86%.
About Clorox
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Featured Stories
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- Hypercharge Networks: Up Triple Digits, But What’s The Big Deal?
- 3 Reasons Why Apple’s 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
